WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 17'1701 Infant (under 12 months) mortality rate: 72
GDP / capita (US$): 24'8961 Child (under 5 years) mortality rate: 82

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 5'446  5'440  5'433  5'425  5'415  5'388  5'278  4'989 
Births 58  58  58  57  56  54  80  97 
Surviving infants 58  58  57  57  56  53  79  95 
Pop. less than 5 years 292  289  282  278  273  288  414  485 
Pop. less than 15 years 819  820  822  832  845  1'062  1'340  1'303 
Female 15-49 years 1'391  1'401  1'411  1'418  1'424  1'448  1'324  1'230 

Number of reported case

(Click for retrospective incidence data for Slovakia)
Diphtheria
Japanese encephalitis
Measles 47 
Mumps 32 
Pertussis 950  936  1'379  288  105  43  194 
Polio*
Rubella 11 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Slovakia)
Vaccine year result method % card seen                                                
BCG          90  97  98  97  98  94 
DTP1          99 
DTP3          99  99  99  99  99  99 
HepB_BD          100  100  100 
HepB3          99  99  99  99  99  98 
Hib3          99  99  99  99  99 
JapEnc         
MCV          99  98  99  99  99  98 
MCV2          99  99  99  99  99  99 
PCV1         
PCV3          99  99  99  99 
Pol3          99  99  99  99  99  98 
Rota1         
Rota_last         
Rubella1          99  98  99  99  99 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Slovakia)
BCG 90  97  98  97  98  94 
DTP1 99  99  99  99  99  99 
DTP3 99  99  99  99  99  99 
HepB3 99  99  99  99  99  98 
Hib3 99  99  99  99  99  59 
MCV 99  98  98  99  99  98 
PCV3 99  99  99  99 
Pol3 99  99  99  99  99  98 
Rota_last

Number of districts in the country 79  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibHepIPV 2, 4, 10 months;
DTaPIPV 5, 12 years; Yes
HepB birth; Yes newborns of HBSaG positive mothers;
Influenza Yes inmates of social care facilities
MMR 14 months; 10 years; Yes
Pneumo_conj 2, 4, 10 months; Yes
Td Yes revaccination of adults each 15 years

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number     not specified  2009-2010  2008-2010  2008-2010  2007 - 2010 
Nº of districts with microplans that include activities to raise immunization coverage number 79  79  79  79  79  79  79 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 79  79  79  79  79  79  79 
Nº districts with DTP3 coverage >=80% number 79  79  79  79  79  79  79 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 79  79  79  79  79     
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100  100  100     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND NA  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  NA  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.